Еріктілер кеңесі

2025 жылдың қыркүйегінде доктор Бернс Балалар денсаулығы сапасы ұлттық институтының (NICHQ) президенті және бас директоры ретінде 10 жыл қызмет еткеннен кейін зейнетке шықты. Бұған дейін ол Марш Димес ұлттық кеңсесінде тарау бағдарламаларының аға вице-президенті және медициналық қызметкердің орынбасары болды.

Доктор Бернс – кеңестің сертификаты бар педиатр және педиатрдың жедел жәрдем дәрігері. Ол Провиденс штатындағы Браун университетінің Уоррен Альперт медициналық мектебінің педиатрия клиникалық профессоры. Ол денсаулық сақтау, саясат және менеджмент саласында шоғырланған Гарвард қоғамдық денсаулық мектебінен қоғамдық денсаулық сақтау магистрі дәрежесін алды және АҚШ көлік хатшысының арнайы көмекшісі қызметін атқарған бір жылдық Ақ үйдегі стипендияны аяқтады.

Доктор Бернс американдық педиатрия академиясының педиатриялық жедел жәрдем медицинасындағы зерттеулердегі үздіктері үшін Уиллис Вингерт сыйлығын, Ұлттық перинаталдық қауымдастықтың ұлттық наградасын, АҚШ Көлік департаментінің қоғамдық денсаулық сақтау саласындағы сыйлығын, Стэн және Мэвис Грейвен көшбасшылық сыйлығын және Ақ үй стипендиаттары қоры мен қауымдастығының әсер ету сыйлығын алды.

Karen Ballack is a partner in the Silicon Valley office of Weil, Gotshal & Manges, LLP. She has extensive experience as an intellectual property transactional attorney, with emphasis on representing technology companies, particularly in the computer, internet, semiconductor, biotechnology, pharmaceutical and medical device industries. Karen represents clients in connection with technology and intellectual property alliances and transactions, including research and development collaborations, licensing matters, corporate partnering transactions, and commercialization arrangements regarding products and services. Karen is often engaged as a guest speaker on these topics. She also serves on the firm’s Pro Bono Committee, Diversity Committee and Women@Weil Leadership Committee and is a member of the Hiring Committee.

Sandra Bresnick retired after serving as Co-Chair of the Global Life Sciences Practice for Quinn Emanuel Urquhart & Sullivan.  Based at the New York office, she specialized in patent litigation, particularly in the areas of pharmaceuticals, medical devices, and biotechnology. Ms. Bresnick also counseled clients on intellectual property management. She teaches Pharmaceutical Patent Litigation at Rutgers University School of Law and is a frequent speaker on topics pertinent to the life sciences industries. She is registered to practice before the U.S. Patent & Trademark Office.

Алан Брогдон стратегиялық көшбасшылық саласында 20 жылдан астам тәжірибесі бар, операцияларға, технологияға және ортақ қызметтерге маманданған білікті басшы. Аналарға мас күйінде көлік жүргізуге қарсы (MADD) технология бойынша бас маман ретінде Алан ұйымның цифрлық трансформацияға, миссияға әсер ету үшін технологиялық инфрақұрылымды, деректер стратегиясын және операциялық тиімділікті арттыруға жетекшілік етеді.

Previously, Alan served as the Chief Operating Officer at The Progeria Research Foundation (PRF), where he spearheaded initiatives to improve operational effectiveness, optimize financial operations, and drive revenue growth through innovative fundraising strategies. Following his tenure as COO, he transitioned to the PRF Board, continuing his commitment to PRF’s mission.

Paula is an Engagement Director within the Client Accounting and Advisory Services of CliftonLarsonAllen. She builds relationships and provides services to clients to help solve their accounting and finance issues, whether it’s project-based or as an interim role.

Paula has more than 25 years of experience in financial management operations, financial reporting, and planning within the manufacturing, private equity, and non-profit industries. She is also a former Assistant Professor of Accounting at Dean College. Paula earned an MBA from Providence College and is a member of the American Institute of Certified Public Accountants.

Дана-Фарбер онкологиялық институтында және Бостон балалар ауруханасында балалар нейро-онкологиясының директоры болған 20 жылдан кейін бас миының қатерлі ісігі, прогериясы және басқа нәрестелердің жүрек аурулары бар балаларға арналған жаңа мақсатты және гендік терапияларды әзірлеуге және клиникалық аудармаға назар аударды, доктор Киран өнеркәсіпке көшті және қазіргі уақытта мақсатты препараттарды дамытуға бағытталған бірінші күндегі биофармацевтиканың клиникалық даму жөніндегі вице-президенті болып табылады. балаларға арналған препараттар.

In addition to a PhD in Immunology from the University of Alberta, Canada and two post-doctoral fellowships in molecular biology (Paris, France) and cellular signal transduction (Harvard, Boston), Mark is also a board-certified pediatric hematologist oncologist. He helped develop and remains on the faculty of the Children’s Cancer Hospital Egypt, the largest pediatric cancer hospital in the world. Mark is also the CEO of Break-Even Therapeutics, a 501c3 working to supply essential medicines to in-need populations around the world.

John is the President/CEO of Bell-Mark Sales Company which designs, manufactures and services high-performance coding, marking and printing equipment for the food, medical device and industrial marketplace worldwide. Founded in 1959 by John’s father, Bell-Mark is now a 3^rd generation family business headquartered in Pine Brook, New Jersey, with manufacturing facilities in Dover, PA, and sales offices around the globe.

John is a member of the Board of Preakness Hills Country Club where he chairs the Tournament Committee. He is also the grandfather of Zoey Penny, diagnosed with Progeria in March 2010 at age 5 months. He and his family formed Зои командасы  to raise funds and awareness in their community and beyond.

Larry Mills has been the Executive Vice President of the Holt Companies, based in San Antonio, Texas for over 40 years. These companies are comprised of HOLT CAT, one of the world’s largest Caterpillar dealers and the four-time NBA Champion San Antonio Spurs. After holding various positions with the companies in the areas of parts operations, marketing, sales and human resources, his areas of focus now include strategic planning, marketing, leadership development, and organizational development.

He is the founder of Holt Development Services, Inc., which is based on the Values Based Leadership approach to business. Larry serves on the board of directors of the San Antonio Spurs, Clarity Child Guidance Center and Children’s Hospital of San Antonio Foundation.  He is also a member of the Society of Human Resource Management, the American Society of Training and Development, and the Ethics Officers Association. 

Liza Morris is a 20+ year veteran of health and science communications. As a strategy and communications consultant, she has worked with organizations to build strategic partnerships; raise awareness in global markets about important science, education and human development issues; create programs to drive fundraising, change perceptions and influence behavior; implement strategies to drive digital conversations; successfully navigate through crisis situations; and establish new programs to measure results. Liza has been working with PRF since 2003 and has helped lead the communications aspect of every major milestone that PRF has achieved.

Kim Paratore is the former Executive Director and Event Coordinator of Grateful Friends, a non-profit based in Gloucester, MA that provides support to adults living with, or undergoing treatment for, cancer. Kim has been involved as a PRF volunteer since its inception, having created and chaired the Night of Wonder galas (PRF’s major fundraiser), as well as numerous other PRF special events. She has also been involved in dozens of fundraising efforts for other charities and her two sons’ schools, organizing races, auctions and dinners. In 2005, Kim was honored with PRF’s coveted Amy Award for her tireless efforts and long-standing commitment to children with Progeria.

Matthew Winters is a Partner at the strategic advisory firm Hakluyt & Co., where he leads much of the firm’s US healthcare work out of Washington, DC. Prior to joining Hakluyt, Matt spent seven years as a Partner at PWR, a boutique law firm where he provided counsel and strategic advice to pharmaceutical and biotechnology companies, and nonprofit organizations, on an array of legal, regulatory, business, and public policy matters.

Previously, Matt served in several senior roles in the Obama Administration, including as Deputy Special Counsel to the President in the White House Counsel’s Office, and as Chief Operating Officer of the Department of Energy’s $50 billion clean energy investment fund. He also worked for several years as an associate at the law firm of Williams & Connolly.